Startseite Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
Artikel Open Access

Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report

  • Pingping Xiao EMAIL logo , Qingqing Wang , Zhigao Dong , Junnan Su , Yongquan Chen und Wei Fan
Veröffentlicht/Copyright: 27. Juni 2024

Abstract

Castleman disease (CD) is a relatively rare lymphoproliferative disorder. Lesions predominantly originate on the chest and neck and rarely occur on the abdomen. A 34-year-old female presented to our hospital with an unexplained 10-year history of anemia. A pathological diagnosis of plasma cell-type CD was established. One cycle of chemotherapy (thalidomide, cyclophosphamide, and prednisolone) improved her anemia significantly. Prompt etiological diagnosis and early intervention are essential to address systemic manifestations in patients with CD, and it is crucial to consider CD as a differential diagnosis when intra-abdominal masses are detected.

1 Background

Castleman disease (CD), a rare, non-neoplastic, lymphoproliferative disorder first described by Castleman et al. in the 1950s, is characterized by localized lymph node hyperplasia. CD is clinically classified into unicentric and multicentric CD (UCD and MCD, respectively) based on the number of regions of enlarged lymph nodes. The diagnosis is based on the pathology of the biopsy mass, with three pathological subtypes identified: hyaline vasculature (HV), plasma cells (PC), and mixed subtypes. The incidence of CD is less than 1 per 100,000, with UCD found to be more predominant in females than in males (2:1 ratio) [1]. Notably, 80–90% of UCD are pathologically HV, whereas 10–20% are PC CD [2]. The most common systemic symptoms include fever, anemia, night sweats, fatigue, and weight loss [3]. UCD has a good prognosis and a 5-year survival rate exceeding 90% and no impact on long-term survival outcomes [4]. Here, we report a patient who experienced unexplained anemia for 10 years that had remained undiagnosed. A lesion observed in the abdominal mass was diagnosed as plasma cell-type UCD (PC-UCD). Anemia improved after one cycle of chemotherapy, resulting in patient recovery.

2 Case presentation

A 34-year-old female presenting with a 10-year history of palpitations and breathlessness was referred to our hospital. Upon physical examination, her findings were as follows: blood pressure, 111/74 mmHg; heart rate, 96 beats/min; and respiratory rate, 19 breaths/min. She did not present with superficial lymphadenopathy, splenomegaly, hepatomegaly, or sternal tenderness and lacked any relevant personal or familial medical history.

Her laboratory blood test results were as follows: hemoglobin (HGB) level, 49.0 g/L (normal range [NR], 110–150 g/L); white blood cell count, 3.86 × 109/L (NR, 4–10 × 109/L); platelet count, 343 × 109/L (NR, 100–300 × 109/L); serum iron, 2.73 µmol/L (NR, 9–27 µmol/L); serum ferritin, 124.90 ng/mL (NR, 11.0–306.8 ng/mL); total iron-binding capacity, 31.92 µmol/L (NR, 45–75 µmol/L); transferrin saturation, 8.55%; serum folate, >53.47 nmol/L (NR, 11.8–50.0 nmol/L); serum B12, 160.63 pmol/L(NR, 180–914 pmol/L); reticulocyte percentage, 1.95% (NR, 0.3–3.0%); serum glutamic oxaloacetic transaminase, 8 IU/L (NR, 13.0–35.0 IU/L); serum glutamic pyruvic transaminase, 4 IU/L (NR, 7.0–40.0 IU/L); serum γ-glutamyl transpeptidase, 30 IU/L (NR, 7.0–45.0 IU/L); serum lactate dehydrogenase, 66.55 IU/L (NR, 100.0–240.0 IU/L). Serum alkaline phosphatase level was elevated (250 IU/L; NR, 35–100 IU/L). Creatine kinase and creatine kinase isoenzyme levels were within the NR. The erythrocyte sedimentation rate (ESR) was 154 mm/h (NR, 0–20 mm/h). Direct and indirect antiglobulin test results were negative, the immunoglobulin A level was 8.20 g/L (NR, 0.70–4.00 g/L), and the immunoglobulin G level was 30.60 g/L (NR, 7.00–16.00 g/L). The results of antinuclear antibody, anti-extractable nuclear antibody, antiphospholipid antibody, antineutrophil cytoplasmic antibody, rheumatoid factor, and anti-cyclic citrullinated peptide tests were negative. Tumor indices, including alpha-fetoprotein, carcinoembryonic antigen, CA199, and CA125, were within the NR. The erythropoietin level was elevated (70.27 mIU/mL; NR, 5.44–26.25 mIU/mL). Thyroid function was normal. The Epstein–Barr virus-DNA level was low (<4.0 × 102 copies/mL). The IgG4 value was 788.9 mg/L (adult NR, 39.2–864 mg/L). There were no abnormalities in both α-thalassemia and β-thalassemia genes. Bone marrow morphology and biopsy revealed proliferative anemia. Flow cytometric analysis detected no developmental abnormalities in the bone marrow. Immunofixation electrophoresis of the serum and urine revealed polyclonal hypergammaglobulinemia. Bone marrow metaphase cytogenetics revealed a 46, XX karyotype.

At admission, computed tomography scans of the chest and whole abdomen were performed, revealing increased T4 and T11 bone density, a compression fracture, splenomegaly, a mid-abdominal mass, and peripheral lymphadenomegaly (Figure 1a–c). A punch biopsy of the abdominal cavity mass was performed under ultrasonographic guidance, and pathological tissues were diagnosed as lymphoid tissue hyperplasia with a significant increase in plasma cells; PC-CD was considered initially. Immunohistological analysis revealed the following findings: plasma cells with CD38, CD138, CD19, Kappa and Lambda positivity, HHV8-negative, CD56-negative, IgG4-scattered positive (approximately 0–5 pcs/HPF), B lymphocytes with CD19 and CD20 positivity, T lymphocytes with CD3 and CD5 positivity, Cyclin D1-negative, and Ki-67 (+5–10%) (Figure 2).

Figure 1 
               Abdominal computed tomography. Before (a)–(c) and after (d)–(f) chemotherapy axial; yellow arrow, upper left mass.
Figure 1

Abdominal computed tomography. Before (a)–(c) and after (d)–(f) chemotherapy axial; yellow arrow, upper left mass.

Figure 2 
               Abdominal cavity mass biopsy: (a) Hematoxylin & eosin staining ×1,000, (b) CD138-positive cells ×1,000, (c) CD38-positive cells ×1,000, (d) CD20-positive cells ×1,000, (e) Kappa-positive cells ×1,000, (f) Lambda-positive cells ×1,000, (g) HHV-8-negative cells ×1,000, (h) IgG 4-scattered positive cells (0–5 cells/HPF) ×1,000, and (i) CD56-negative cells, ×1,000.
Figure 2

Abdominal cavity mass biopsy: (a) Hematoxylin & eosin staining ×1,000, (b) CD138-positive cells ×1,000, (c) CD38-positive cells ×1,000, (d) CD20-positive cells ×1,000, (e) Kappa-positive cells ×1,000, (f) Lambda-positive cells ×1,000, (g) HHV-8-negative cells ×1,000, (h) IgG 4-scattered positive cells (0–5 cells/HPF) ×1,000, and (i) CD56-negative cells, ×1,000.

No clinically relevant or possibly pathogenic variants were identified using whole exome sequencing. Consequently, a diagnosis of PC-UCD was established. Following a multidisciplinary evaluation and communication with the patient, one cycle of chemotherapy (thalidomide, 75 mg/day; cyclophosphamide, 400 mg once a week; prednisolone, 40 mg twice a week) was administered. The size of the enlarged abdominal cavity mass did not decrease significantly (Figure 1d–f). However, her HGB levels gradually increased while her globulin level decreased. No reduction in C-reactive protein (CRP), ESR, fibrinogen (Fbg), and interleukin (IL)-6 levels were observed (Figure 3). The patient was able to engage in physical activities.

Figure 3 
               Changes in indices pre- and post-chemotherapy. HGB, hemoglobin; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; Fbg, fibrinogen; IL-6, interleukin-6; RBC, red blood cell; TCP, thalidomide, cyclophosphamide, prednisolone.
Figure 3

Changes in indices pre- and post-chemotherapy. HGB, hemoglobin; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; Fbg, fibrinogen; IL-6, interleukin-6; RBC, red blood cell; TCP, thalidomide, cyclophosphamide, prednisolone.

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.

3 Discussion

Herein, the patient had a 10-year history of unexplained anemia, with a significant reduction in her HGB level observed in the most recent 2 years. Anemia is more common in MCD and is rarely reported in UCD. Some cases of PC-UCD associated with iron deficiency anemia have been reported [58]. However, our patient failed to meet the diagnostic criteria for iron deficiency anemia in the previous 10 years. Oksenhendler et al. reviewed 57 patients with UCD, including 13 patients with an original mass in the abdominal cavity and only one patient with anemia [9]. Additionally, Patel et al. reported 791 adult cases, among whom 376 patients had anemia; however, the authors did not differentiate between UCD and MCD [10]. According to the current literature, the UCD type is associated with a low incidence of anemia, especially severe anemia. Our patient had experienced severe anemia for 10 years, during which she had fainted due to anemia on several occasions and required emergency transport to a hospital by ambulance.

We focused on related indicators, including ESR, CRP, Fbg, and IL-6 values, with higher values of these indices observed pre-chemotherapy (Figure 3). Subsequent blood analysis results revealed elevated HGB levels and reduced globulin, indicating improvement in her condition. However, her ESR, CRP, IL-6, and Fbg levels failed to improve significantly. CD is associated with elevated CRP and IL-6 levels [11]. In our patient, these levels had increased significantly prior to diagnosis and treatment. High levels of inflammatory indices after treatment, including ESR, CRP, IL-6, and Fbg, persisted, indicating the presence of substantial inflammation.

Compared with other factors such as ESR, CRP, and Fbg, IL-6 plays a pivotal role in hepcidin regulation in the pathogenic cascade that induces CD-related anemia; this cascade is initiated via IL-6-mediated hepcidin induction and subsequently results in anemia [12]. Genetic and molecular abnormalities in CD have been identified in novel subtype-specific pathways; for example, the over-representation of genes involved in collagenous fibrosis has been detected in UCD. Moreover, complement effector C3 and components of the classical component pathway (UCD: C1S and C1R) were found to be upregulated, suggesting that complement activation plays a role in the B-cell activation/plasma cell differentiation and the inflammatory response observed in UCD [13]. The mammalian target of rapamycin and Janus kinase signal transducer and activator of transcription pathways have been identified as potential therapeutic targets [14,15]. In UCD, severe clinical manifestations may be associated with molecular alterations in these pathways [16]. FAS, PDGFRB, FGFR3, NF1, and TGFBR2 were identified as the most commonly affected genes involved in mitogen-activated protein kinase pathways in UCD [17]. Biomarkers IL6ST, PDGFRB, DPP6, and MUC4 are the most frequently mutated genes in paraneoplastic pemphigus-associated UCD [18]. Moreover, chromosome abnormalities were found to involve chromosome 7 in UCD [19]. Our patient had a normal female karyotype (46, XX). Additionally, whole exome sequencing did not identify any related genes. Accordingly, the mechanism underlying anemia occurrence appears to be markedly complicated in PC-UCD and does not merely involve IL-6, which explains the improved anemia without a reduction in the persistently elevated IL-6 level post-treatment.

Therefore, optimal treatment options for our patient merit further investigation. Based on these findings, the next suggested line of treatment is either surgical excision of the mass or other chemotherapy regimens. Furthermore, we reviewed recent literature regarding the treatment of UCD. Talat et al. examined 278 patients with UCD, of whom 49 had abdominal cavity involvement and underwent surgery (97.1%). The authors reported a 10-year cumulative survival rate of >90% [20]. Boutboul et al. assessed 71 patients with UCD, 19 of whom had an abdominal cavity mass, and 11 had anemia. Of the 71 patients, 47 underwent surgery, of whom 43 (91%) achieved complete remission postoperatively. The estimated 5-year overall survival rate of 71 patients with UCD was 98.4% [21]. Guo et al. evaluated 118 patients with UCD, seven of whom underwent surgery as the primary treatment, achieving a 5-year overall survival of 88.1% [22]. Rodriguez et al. reported a 29-year-old female with a pelvic presentation of UCD, which was successfully treated with radiotherapy combined with chemotherapy regimens, thereby demonstrating promise in unresectable cases [23]. Surgery may be mutilating and associated with a high risk of complications. Radiotherapy and chemotherapy have been proposed to address unresectable tumors. Nevertheless, alternative options should be discussed. Our patient experienced poor general condition and could not tolerate surgical intervention. As outlined previously, our patient’s abdominal mass showed low Ki-67 expression. Ki-67, a cell proliferation marker, has been detected in several cancer types, including non-Hodgkin lymphomas, multiple myeloma, soft tissue sarcoma, prostate cancer, and breast cancer, with Ki-67 exhibiting prognostic value in predicting cancer survival rates and the likelihood of relapse [24]. Considering our patient, the abdominal mass with low Ki-67 expression (+5–10%) suggested low proliferative capacity. Consequently, we selected chemotherapy to improve anemia rather than initial surgical intervention. The treatment was the same as that for MCD. Prior to the UCD diagnosis, our patient had relied on recurrent red blood cell (RBC) transfusions. Post-diagnosis, the patient received one cycle of chemotherapy, which improved anemia and ceased the need for RBC transfusions. Currently, the patient undergoes regular follow-up, with elective surgery planned in the near future. Based on the findings in our case, one limitation is that anemia needs to be improved with appropriate chemotherapy prior to undertaking surgery in patients with PC-UCD. To address systemic complications such as severe anemia, chemotherapy may be an alternative therapy.

4 Conclusion

Although most patients with UCD have long survival, systemic manifestations, such as fever and severe anemia, impact their quality of life. Early etiological diagnosis is essential for patients with combined systemic symptoms, such as severe anemia observed in our case. Prompt selective surgery or medical treatment is the first step following a comprehensive evaluation.

Acknowledgements

The authors would like to acknowledge the hard and dedicated work of all the staff. They also appreciate the selfless dedication of the patient.

  1. Funding information: This work was supported by the Natural Science Foundation of Fujian (No. 2023J011640).

  2. Author contributions: P.P.X. drafted and wrote the manuscript; Z.G.D. and Y.Q.C. supervised and followed up on the case; and Q.Q.W., J.N.S., and W.F. collected the relevant data. All authors contributed to and approved the submitted manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Pertusa Mataix R, Loaiza Cabello D, Garcia Morillo JS. Castleman’s disease, pathophysiology, advances in diagnosis and treatment. Med Clin (Barc). 2024;162(6):283–90.Suche in Google Scholar

[2] Kishore A, Rana N, Kumar A, Kashyap V, Jebaying Y. Hyaline vascular variant of castleman disease of the tonsil in an adolescent: a case report. Indian J Otolaryngol Head Neck Surg. 2024;76(1):1062–5.Suche in Google Scholar

[3] Hoffmann C, Hentrich M, Tiemann M, Rosenwald A, Weber F, Willenbacher W, et al. Recent advances in castleman disease. Oncol Res Treat. 2022;45(11):693–704.Suche in Google Scholar

[4] Van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, et al. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv. 2020;4(23):6039–50.Suche in Google Scholar

[5] Yin L, Lu XY, Xu F, Li AJ, Wu MC. Unicentric Castleman’s disease presenting with growth retardation and iron deficiency anemia. Am J Med Sci. 2012;343(5):426–8.Suche in Google Scholar

[6] Chandrakasan S, Bakeer N, Mo JQ, Cost C, Quinn CT. Iron-refractory microcytic anemia as the presenting feature of unicentric Castleman disease in children. J Pediatr. 2014;164(4):928–30.Suche in Google Scholar

[7] Suh JH, Hong SH, Jeong SC, Park CB, Choi KB, Shin OR, et al. Anemia resolved by thoracoscopic resection of a mediastinal mass: a case report of unicentric Castleman’s disease. J Thorac Dis. 2015;7(7):E189–93.Suche in Google Scholar

[8] Kalayoglu Besisik S, Yonal Hindilerden I, Hindilerden F, Dogan IO, Besisik F. A rare cause of unexplained refractory iron deficiency anemia: unicentric plasma-cell type castleman’s disease. Turk J Haematol. 2016;33(3):257–8.Suche in Google Scholar

[9] Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, et al. The full spectrum of Castleman disease: 273 patients studied over 20 years. Br J Haematol. 2018;180(2):206–16.Suche in Google Scholar

[10] Patel R, Patel D, Onyechi A, Shaikh S, Patel M, Patel Z. Castleman disease- demographics, associations, and outcomes: an analysis of adult 791 cases. Ann Hematol. 2024;103(4):1255–60.Suche in Google Scholar

[11] Gonzalez Garcia A, Fernandez-Martin J, Robles Marhuenda A. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis. Rheumatology. 2023;62(4):1426–35.Suche in Google Scholar

[12] Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood. 2010;116(18):3627–34.Suche in Google Scholar

[13] Van Rhee F. Nearly 70 years later: the continued unraveling of Castleman disease. Haematologica. 2023;108(1):7–8.Suche in Google Scholar

[14] Arenas DJ, Floess K, Kobrin D, Pai RL, Srkalovic MB, Tamakloe MA, et al. Increased mTOR activation in idiopathic multicentric Castleman disease. Blood. 2020;135(19):1673–84.Suche in Google Scholar

[15] Fajgenbaum DC, Langan RA, Japp AS, Partridge HL, Pierson SK, Singh A, et al. Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease. J Clin Invest. 2019;129(10):4451–63.Suche in Google Scholar

[16] Nagy A, Bhaduri A, Shahmarvand N, Shahryari J, Zehnder JL, Warnke RA, et al. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Blood Adv. 2018;2(5):481–91.Suche in Google Scholar

[17] Butzmann A, Kumar J, Sridhar K, Gollapudi S, Ohgami RS. A review of genetic abnormalities in unicentric and multicentric castleman disease. Biology. 2021;10(4):1–11.Suche in Google Scholar

[18] Wang S, Wang R, Shang P, Zhu X, Chen X, Zhang G, et al. Whole-exome sequencing reveals the genomic profile and IL6ST variants as a prognostic biomarker of paraneoplastic pemphigus-associated unicentric castleman disease. J Invest Dermatol. 2024;144(3):585–92.e1.Suche in Google Scholar

[19] Chromosome 7: Human Genome Landmarks Poster. Available online: https://web.ornl.gov/sci/techresources/Human_Genome/posters/chromosome/chromo07.shtml (accessed on 13 July 2020).Suche in Google Scholar

[20] Talat N, Belgaumkar AP, Schulte KM. Surgery in Castleman’s disease: a systematic review of 404 published cases. Ann Surg. 2012;255(4):677–84.Suche in Google Scholar

[21] Boutboul D, Fadlallah J, Chawki S, Fieschi C, Malphettes M, Dossier A, et al. Treatment and outcome of Unicentric Castleman disease: a retrospective analysis of 71 cases. Br J Haematol. 2019;186(2):269–73.Suche in Google Scholar

[22] Guo M, Nong L, Wang M, Zhang Y, Wang L, Sun Y, et al. Retrospective cohort evaluation of non-HIV Castleman disease from a single academic center in Beijing, China. Ann Hematol. 2024;103(1):153–62.Suche in Google Scholar

[23] Rodriguez C, Rivera Rubi L, Menjivar O, Suazo J. The role of radiation therapy in unicentric castleman disease: a case report. Cureus. 2023;15(11):e49687.Suche in Google Scholar

[24] Remnant L, Kochanova NY, Reid C, Cisneros-Soberanis F, Earnshaw WC. The intrinsically disorderly story of Ki-67. Open Biol. 2021;11(8):210120.Suche in Google Scholar

Received: 2024-02-24
Revised: 2024-05-25
Accepted: 2024-05-29
Published Online: 2024-06-27

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
Heruntergeladen am 24.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0898/html
Button zum nach oben scrollen